Gene Tests: Progress And Pandora's Box

Main Category: Genetics
Article Date: 05 Dec 2008 - 5:00 PDT

email to a friend   printer friendly   view / write opinions

Personalized medicine based on an individual's genes inched closer to routine use this year.

Doctors have started to order gene tests to assess how sensitive people are to the blood thinner warfarin (Coumadin), although there are some doubts about how useful such tests will be. Meanwhile, many direct-to-the-consumer genetic tests hit the market.

The tests have raised some concerns. Will they be done correctly? And even if they are, the predictive powers of this early generation of gene tests might be oversold, so some people could be unduly scared while others are falsely assured.

Harvard Health Letter

It's important to keep up with the medical news that affects your health and well-being. It's even better when the facts come directly from the more than 8,000 doctors and researchers at Harvard Medical School. There is no more trustworthy source of medical research articles and advice than the Harvard Health Letter .

The Harvard Health Letter is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $24 per year. Subscribe at http://www.health.harvard.edu/health or by calling 877-649-9457 (toll-free).

Harvard Health Letter